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The Thames Cancer Registry (TCR) has, unfortunately, a long-
standing history of high rates of registrations by death certificates
only (DCO registrations). A study of all malignant neoplasms
recorded by the TCR between 1987 and 1989 inclusive estimated
that DCOs accounted for around 24% of all registrations (Pollock
and Vickers, 1995). In 1992, the DCO rate was 20% (Thames
Cancer Registry, 1995).
Each UK registry receives notification of all deaths occurring
on its territory where cancer is mentioned on the death certificate.
In the case of the TCR, about half of these patients identified from
death certificates will already be known. The rest must be traced
by following up case notes at local hospitals and treatment centres.
Those cases not traced are defined as death certificate only regis-
trations, or DCOs (Jensen et al, 1991). The TCR has attributed the
high proportions of DCO registrations to the decision taken in
1983 (for financial reasons) not to follow up cases dying at home
and to the amalgamation in 1985 into its territory of the North
Thames region.
As the TCR contributes up to a third of England and Wales data,
these high rates could bias regional and national survival analyses
(Pollock and Vickers, 1994). (DCOs are excluded from survival
analysis because it is rarely possible to confirm a date of diagnosis
(Jensen et al, 1991).) They also cast doubt on the accuracy of
regional and national incidence data because of a relatively high
frequency of imprecision in certification of cause of death and data
artefacts which can result in underreporting (Percy et al, 1981;
Chow and Deveas, 1992; Gruhlich et al, 1995).
In recent years, the TCR has undertaken to reduce DCO rates.
Analyses of FHSA data have increased ascertainment of cases
seen outside National Health Service (NHS) acute settings. The
registry has also gained access to the computerized information
systems of some hospitals which had failed to provide manuscript
case notes. Although these measures have helped to lower the
proportion of DCOs, more dramatic reductions must be achieved if
the TCR is to meet the requirements of the new Core Contract for
cancer registries which came into effect in April 1996. The Core
Contract sets standards of data quality that must be reached in the
near future. For all cancers, DCOs should account at present for no
more than 5% of registrations and a target rate of 2% has been set
to be reached ‘within 3 years’ (EL(96)7, Annex A).
There is evidence to suggest that the largest reductions will be
achieved by more effective ascertainment of cases seen in NHS
acute hospitals. A study of factors associated with DCO registra-
tions between 1987 and 1989 found that 40.5% of DCO cases died
in NHS acute hospitals (Pollock and Vickers, 1995). This leaves
out of account those cases seen in NHS hospitals who died else-
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where. In a case note study of colorectal cancer treatment in four
districts covered by the TCR, case notes were retrieved on (58%)
DCO cases registered by the TCR (Pollock and Vickers, 1994).
In view of this potential for a reduction of DCOs, we analysed a
sub-sample of cases (all registrations for the three most common
cancers, viz. colorectal, lung and female breast (ICD-9: 153/154,
162, 174)) to examine the extent to which TCR data could be
linked to hospital episodes statistics (HES) data. These are data
submitted to the Department of Health (DoH) by NHS hospitals on
all the patients they admit. They are collected in the form of
‘finished consultant episodes’ (FCEs) – episodes ‘where a patient
has completed a period of care under a consultant and is either
transferred to another consultant or is discharged’ (Government
Statistical Service, 1993). National returns of FCE data are not
named and, as no unique identifier is used in England and Wales,
they cannot readily be linked to other data sets such as cancer
registries. This is one of the reasons national data have not been
used before in this way.
In this paper we have attempted to overcome this problem
through the use of probability matching (i) to match and link FCEs
that appear to refer to individual patients; and (ii) to match these
putative patients to patients listed in the TCR. We then considered
some of the factors associated with successful HES/TCR matching
and DCO retrieval in multiple logistic regression models.
Previous studies linking cancer registry data with electronic
data have focused on pathology databases, and have used these to
measure rates of ascertainment by the registry. We believe HES
data are too crude to fulfil this aim. But they may be useful in
tracing records that have not been included by the registry system.
METHODS
Cancer registry data were requested from the Thames Cancer
Registry on all residents of the Thames Regions (North and South)
diagnosed with a malignant neoplasm of the colon, rectum, lung
or breast (ICD-9: 153, 154, 162, 174) between 1 April 1991 and
31 March 1994 aged < 100 at diagnosis. Colorectal cancers were
treated as a single category. Cancer of the lung refers to lung,
trachea and bronchus. These data formed the reference data set.
HES data were requested from the Office of National Statistics
(ONS) on all FCEs completed for residents of the Thames regions
between 1 April 1991 and 31 March 1994 inclusive with a primary
diagnosis of any of three cancers of interest aged < 100 at
diagnosis.
Matching was carried out in two stages. The first stage used just
HES data matching and linking episodes to different admissions
that seemed to refer to the same patients. This was done using full
date of birth, seven-character postcode and sex as index variables.
Full accounts of the method and its assumptions have been
published by Gill et al (1993) and Majeed and Voss (1995). The
key assumption is that all FCEs with identical values in the index
variables related to a single patient.
The second stage – using the same method – was used to match
HES data to TCR data. Two matches were carried out sequentially,
using slightly different matching criteria. The first (Match 1) was
strictest: 3-digit ICD code, full date of birth (dd/mm/yyyy), sex
and seven-character home postcode. The second (Match 2) was
less strict: 3-digit ICD code, year and month of birth and the first
four characters of the home postcode. Match 2 was carried out
Table 1 Procedures in HES data
OPCS code Procedure OPCS code Procedure
Endoscopy Surgery
Colorectal cancer (ICD-9: 153, 154)
H20 Endoscopic extirpation of lesion of H04 Total excision of colon and rectum
H21 Other therapeutic endoscopic H05 Total excision of colon
H22 Diagnostic endoscopic H06 Extended excision of right
H23 Endoscopic extirpation of lesion of H07 Other excision of right hemicolon
H25 Diagnostic endoscopic H08 Excision of transverse colon
H26 Endoscopic extirpation of lesion of H09 Excision of left hemicolon
H27 Other therapeutic endoscopic H10 Excision of sigmoid colon
H28 Diagnostic endoscopic H11 Other excision of colon
H33 Excision of rectum
H47 Excision of anus
H48 Excision of lesion of anus
Z94 Laterality of operation
Cancer of the lung, trachea or bronchus (ICD-9: 162)
E52 Other operations on bronchus E46 Partial extirpation of bronchus
E54 Excision of lung E47 Other open operations on
E55 Open extirpation of lesion of lung E48 Therapeutic fibreoptic endoscopic
E57 Other open operations on lung E49 Diagnostic fibreoptic endoscopic
E59 Other operations on lung E50 Therapeutic endoscopic operations
Z94 Laterality of operation E51 Diagnostic endoscopic
Female breast cancer (ICD-9: 174)
B27 Total excision of breast B32 Biopsy of breast
B28 Other excision of breast
B29 Reconstruction of breast
Z94 Laterality of operation
For all three tumour sites the procedure code for chemotherapy was X35. There is no code for radiotherapy.
714 AM Pollock and N Vickers
British Journal of Cancer (2000) 82(3), 712–717 © 2000 Cancer Research Campaign
only on cases unmatched in Match 1. The potential reductions in
DCO rates for the total three years were computed.
To test the significance of the association between HES/TCR
matching and certain patient characteristics recorded by the
registry, a backwards, step-wise, multiple logistic regression
model was generated. Matching was the outcome variable (yes,
no) and age group (< 75, 75 or older) and Regional Health
Authority of residence were the explanatory variables. The
strength of the association was measured by taking the change in
deviance arising from the inclusion of each variable as an approxi-
mate c 2. All variables were modelled as categorical variables. The
changes in the probability of matching associated with each
variable were expressed as odds ratios.
The number of admissions was computed for matched DCO
cases, stratified by tumour site and by the type of admission
(ordinary in-patient, day case in-patient, and other) and the mode
of admission (elective, emergency, other) recorded in the HES data
set. HES coding defines variables according to specific criteria.
Day-case admissions are in-patient admissions ‘given electively
during the course of a day for care or treatment which can be
completed in a few hours’. Regular day or regular night atten-
dances of wards are not counted as day-case admissions. Elective
admissions are planned admissions. Emergency admissions are
defined as ‘admissions made at short notice at the request of
Accident and Emergency services, general practitioners, bed
bureaux or consultant out-patient clinics’. A third category, ‘other
admissions’, also exists designating maternity FCEs and elective
FCEs where a patient has been transferred from another health
care provider (Government Statistical Service, 1993).
Procedures in the HES data were divided into four categories:
(1) endoscopic, (2) surgical, (3) chemotherapeutic and (4) all
others. The procedures in the HES data comprising category 1 and
2 are listed in Table 1. The number and percentage of patients to
receive a treatment was computed by tumour site. Some common
procedures for cancer, such as radiotherapy, are not classified in
the standard Classification of Procedures used (OPCS 4).
RESULTS
A total of 67 752 registrations of the chosen sites of cancer were
identified in the TCR. Matches were found in the HES dataset for
(66%) (Table 2). The proportion of cases retrieved for each tumour
site was: 72% for colorectal cancer; 62% for cancer of the lung;
and 65% for female breast cancer. For all three tumour sites the
proportion of matches found for patients registered from hospital
case notes was higher than the proportion found for patients regis-
tered as DCOs (P < 0.0001 for all three tumour sites). Among
patients registered from hospital case notes, the proportions
retrieved were: 78% for colorectal cancer; 68% for cancer of the
lung; and 69% for female breast cancer. The corresponding
proportions for cases registered as DCOs were: 44% for colorectal
cancer; 46% for cancer of the lung; and 37% for female breast
cancer.
If all of the matched DCO cases were followed up and case
notes found for each, the proportion of DCOs for each tumour site
would fall from 16% to 11% for colorectal cancer, from 24% to
13% for cancer of the lung, and from 11% to 7% for female breast
cancer (Table 3). As a proportion of the total, DCOs would fall
from 17% to 10%, equivalent to a reduction in the DCO rate of
43%.
Table 2 Number (%) of matched cases By tumour site and final source of cancer registration
Match All cases Case notes DCOs
Colorectal cancer (ICD-9: 153. 154)
Match 1 12495 (63.5) 11455 (69.3) 1040 (33.1)
Match 2 1681 (8.6) 1349 (8.2) 332 (10.6)
No match 5484 (27.9) 3714 (22.5) 1770 (56.3)
Total 19660 (100) 16518 (100) 3142 (100)
Cancer of the lung, trachea and bronchus (ICD-9: 162)
Match 1 13924 (51.9) 11818 (57.6) 2106 (33.4)
Match 2 2805 (10.5) 2024 (9.9) 781 (12.4)
No match 10074 (37.6) 6656 (32.5) 3418 (54.2)
Total 26803 (100) 20498 (100) 6305 (100)
Female breast cancer (ICD-9: 174)
Match 1 13208 (56.7) 12541 (60.4) 667 (26.4)
Match 2 1975 (8.5) 1711 (8.2) 264 (10.4)
No match 8106 (34.8) 6506 (31.4) 1600 (63.2)
Total 23289 (100) 20758 (100) 2531 (100)
Table 3 Potential reductions in DCO rates by electronic matching
Tumour site DCO rates
Before matching % After matching %
Colorectal cancer 3142/19660 16 1770/19660 11
Cancer of the lung, trachea or bronchus 6305/26803 24 3418/26803 13
Female breast cancer 2531/23289 11 1600/23289 7
All 11978/69752 17 6788/69752 10
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The results of the multiple logistic regression analyses are
presented in Table 4. Diagnosis below age 75, tumour site (ranked
by prognosis – with cancer of the breast which has the best prog-
nosis as reference) and residence in North Thames region were all
positively associated with successful matching (P < 0.0001 in all
three cases). The factor that accounted for the greatest difference
in the deviance of the models was tumour site.
For all three tumours sites, the largest single proportion of
matched DCOs were admitted through emergency as ordinary in-
patients (Table 5). Smaller proportions were also admitted for day
case procedures. The admission : patient ratios for ordinary in-
patient admissions were 1.5 for colorectal cancer, 1.4 for cancer of
the lung and 1.9 for female cancer of the breast. The equivalent
ratios for day-case admissions were 4.1,1.1, and 3.0.
The proportion of matched DCO cases admitted as ‘other’
admissions (i.e. neither elective nor emergency) is significantly
greater than the proportion of all cases admitted by this mode: for
matched DCO cases, 17% (colorectal), 12% (lung, tracheal or
bronchial cancer), and 17% (female breast cancer) (not shown in a
Table). The equivalent figures for all cases in the HES database
were 1%, 2% and 1%.
A higher proportion of matched colorectal DCO cases had a
surgical procedure (48%) and a lower proportion of lung cancers
DCOs (8%) than was the case for cancer of the breast (21%). Few
matched breast DCOs had an endoscopic procedure (only 4%
compared with 17% and 22% for the other two sites). Overall,
76% of matched colorectal DCOs had at least one procedure
compared with 53% for cancer of the lung and 49% for cancer of
the breast (Table 6).
Table 4 Multiple logistic regression model, factors associated with matching
Variable Sub- No. matched/ c 2 DF Odds ratio
variable no. sought
(%)
Age <75 2217/4552 (48.7) Reference
75 + 3342/8916 (37.5) 61.66 1 0.73 (0.67, 0.78)
Tumour site Breast 1209/3217 (37.5) Reference
Colorectum 1385/3533 (39.2) 1.20 (1.08, 1.32)
Lung 2965/6718 (44.1) 56.02 2 1.43 (1.30, 1.56)
Region S Thames 2060/7386 (27.9) Reference
N Thames 3499/6079 (57.5) 1132.11 1 3.45 (3.21, 3.71)
P < 0.0001 for all variables.
Table 5 Number of admissions (number of patients) for matched DCOs by tumour site, type of admission and mode of admission
Mode of admission Type of admission Total %
Ordinary Day case
in-patients in-patients
Colorectal cancer (ICD-9: 153, 154)
Elective 692 (452) 346 (84) 1038 (536) 45.8 (37.1)
Emergency 954 (661) 3 (2) 957 (663) 42.2 (45.8)
Othera 37 (13) 234 (234) 271 (247) 12.0 (17.1)
Total 1683 (1126) 683 (320) 2266 (1446) 100 (100)
Cancer of the lung, trachea or bronchus (ICD-9: 162)
Elective 1000 (588) 424 (376) 1424 (964) 34.3 (31.3)
Emergency 2315 (1749) 4 (4) 2319 (1753) 55.7 (57.0)
Othera 94 (49) 310 (310) 404 (359) 9.8 (11.7)
Total 3409 (2386) 738 (690) 4147 (3076) 100 (100)
Female breast cancer (ICD-9: 174)
Elective 624 (316) 278 (92) 902 (408) 48.6 (40.7)
Emergency 749 (419) 9 (3) 758 (422) 42.0 (42.1)
Othera 35 (10) 162 (162) 167 (172) 9.0 (17.1)
Total 1408 (745) 449 (257) 1857 (1002) 100 (100)
aOther: this category includes maternity FCEs and elective FCEs where a patient is transferred from another health care provider.
Table 6 Number (%) of procedures recorded for matched DCO cases
ICD Code n Endoscopy Surgery Chemotherapy Other listed All procedures
procedures
153/154 1372 238 (17.3) 662 (48) 33 (2.4) 298 (21.7) 1049 (76.4)
162 2887 627 (21.7) 219 (7.6) 87 (3.0) 461 (16.0) 1514 (52.4)
174 931 35 (3.8) 194 (20.8) 53 (5.7) 207 (22.2) 450 (48.3)
Total 5190 900 (17.3) 1075 (20.7) 173 (3.3) 966 (18.6) 3013 (58.1)
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DISCUSSION
Our study suggests that electronic linking of TCR and HES data
might result in reductions of up to 43% in the proportion of cases
registered as DCOs. The greatest reductions are likely to be made
among the under-75s, among North Thames residents and among
patients with tumours with poorer prognosis. There may also be a
high proportion of patients transferred from other hospitals among
the DCO cases. This is reflected in the higher proportion of
patients admitted as ‘other’ admissions. The pattern of admissions
found for DCO cases is distinguished from that of the HES data-
base as a whole by the high proportion of patients admitted as
‘other’ admissions. This category comprises treated by maternity
services and elective patients transferred from other hospitals. In
view of the age and sex distribution of the data used for this study,
it is unlikely that many cases would fall into the first category. We
might expect it to be harder for registry clerks to trace notes on
patients transferred from other hospitals since institutional respon-
sibilities may become blurred in such cases; if so, then the high
proportions of patients admitted for ‘other’ admissions among
matched DCO cases might be a consequence of this difficulty.
Further research is warranted to investigate this hypothesis.
It has been demonstrated elsewhere that DCO registration in the
Thames regions is significantly associated with district of
residence, old age, high tumour severity and dying at home
(Pollock and Vickers, 1995). The associations with successful
matching of DCOs detected here reflect these results.
The biggest reductions were achieved in relation to cancers of
the lung, trachea or bronchus, the tumour site with the poorest
survival rate and the highest proportion of DCOs. The lowest were
found for female breast cancer, the tumour site with the best
survival rate and the lowest proportion of DCOs. It is likely that
the failure of follow-up and ascertainment is greatest among
patients with more lethal cancers, since there will be less time in
which to register them during life. The higher proportion of
HES/TCR matched cases among North Thames residents might,
likewise, be due to poorer cancer registration follow-up and ascer-
tainment in that region. The lower proportion of matches among
DCOs aged 75 or over may be due to the fact that a higher propor-
tion of patients in this age group finish their care in residential
homes. As their clinical case notes may go with them, they may be
lost to the NHS and so not appear in the HES data. The earlier
study found an interaction between age over 75 and patients
finishing their care in residential homes (Pollock and Vickers,
1995). Further research is required to investigate all these
hypotheses.
Fifty-eight per cent of matched DCO cases had at least one
procedure recorded: 76% for colorectal cancer, 53% for breast
cancer and 49% for female breast cancer. It should be borne in
mind that these are minimum estimates. Some common proce-
dures for cancer, such as radiotherapy, are not classified in the
standard Classification of Procedures used (OPCS 4). There are
doubts too about the assiduousness with which providers record
treatments. The unit of contracting is the FCE, not the treatment;
while there are financial penalties for failing to list FCEs, there are
no incentives to account for treatments comprehensively. The clas-
sification system used to code procedures in the HES data set
(OPCS 4) has no code for many treatments (Office of Population
Censuses and Surveys, 1990); radiotherapy is among these. It is
likely that some records with no procedures listed received a
procedure labelled as ‘other’.
Record matching
Two sets of data-matching were carried out for this study. The
pitfalls associated with the first stage (linking HES data to make
them patient-based) have been discussed by Gill et al (1993) Three
main sources of error can affect such matching but, in fact, are
unlikely to have had much impact in the present study. The first
stems from the assumption that records with the same ICD-9,
seven-digit postcode, date of birth and sex relate to a single
patient. Given the large spread of birth dates in our sample (such
that few patients will share the same date) and the large number of
postcodes (in comparison with the relative rarity of cancer in the
population as a whole), the numbers of birth dates in our sample,
and the large numbers of postcodes and the incidence of these
cancers in the population as a whole, the probability of this
assumption being false is very low. A more likely source of error is
from coding mistakes. If there is inconsistency in the recording of
any of the index variables, our method will assign the FCE to
another patient record and this would lead to overestimation of
patient numbers. However, since, in the case of DCOs, we are
interested in the earliest hospital contact recorded, this should not
affect the matching of cancer registry data with HES data. Lastly,
the method of record linkage makes no allowance for patients
moving home between FCEs. This could lead to an overestimate
of new patient numbers. Again, however, the emphasis on the
earliest contact should mean that this has little effect in the present
study.
The second stage (matching cancer registry data to HES data)
uses two sets of matching criteria. Both are extremely stringent
(i.e. the probability of a valid match is close to 1), but here again
mistakes in coding for any of the index variables will mean that
true matches are missed.
The registry is currently examining proposals to move to elec-
tronic data collection through linkage to hospital database systems.
Initially, matching would take place using named data (these are
available at regional but not at national level). Thereafter, NHS
number (a unique identifier) would be used. At present NHS
number is not used by all NHS providers. In both cases, the
proportion of successfully matched cases should be higher than
those reported here. (The first stage of matching outlined here
would not be necessary with named data.)
CONCLUSION
Our experience of HES data suggests that the registry should
proceed with care. HES data are less complete than cancer registry
data. The lack of a specific code for procedures such as radio-
therapy and the probable underreporting of procedures within
FCEs mean that the registry should rely on HES data only for
cases that have not been ascertained by the usual means, e.g.
DCOs and here only as an aid to tracing records that have been
missed by routine registry procedures. The many deficiencies of
HES data mean HES data are a poor substitute for conventional
cancer registry ascertainment. However, this study suggests that
HES data can be used as an aid to the follow-up of known cases.
A prospective study is required to establish the extent to which
the potential reductions identified in this study are achievable in
practice.
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